Impacts of Iron Metabolism Dysregulation on Alzheimer’s Disease
Authors:
- 20 April 2021
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 80 (4) , 1439-1450
Abstract
Background: Iron plays an important role in maintaining cell survival, with normal iron trafficking known to be regulated by the ceruloplasmin-transferrin (Cp-Tf) antioxidant system. Disruption to this system is thought to be detrimental to normal brain function. Objective: To determine whether an imbalance of iron and the proteins involved in its metabolism (ceruloplasmin and transferrin) are linked to Alzheimer’s disease (AD) and to the expression of amyloid-beta (Aβ) peptide 1–42 (Aβ1–42), which is a major species of Aβ, and the most toxic. Methods: We evaluated the concentrations of iron, calcium, magnesium, and Aβ1–42 in the cerebrospinal fluid (CSF) of patients with AD and cognitively normal controls. Correlations between the components of the Cp-Tf antioxidant system in plasma were studied to determine the role of peripheral blood in the onset and/or development of AD. We used commercial ELISA immunoassays to measure Aβ1–42, immunoturbidimetry to quantify ceruloplasmin and transferrin, and colorimetry to quantify iron, calcium, and magnesium. Results: We found that the AD group had lower CSF concentrations of Aβ1–42 (p < 0.001) and calcium (p < 0.001), but a higher CSF concentration of iron (p < 0.001). Significantly lower plasma concentrations of ceruloplasmin (p = 0.003), transferrin (mean, p < 0.001), and iron (p < 0.001) were observed in the AD group than in cognitively normal adults. Moreover, we found a strong interdependence between most of these components. Conclusion: Iron dyshomeostasis has a crucial role in the onset of AD and/or its development. Correcting metal misdistribution is an appealing therapeutic strategy for AD.Keywords
This publication has 75 references indexed in Scilit:
- Effects of NMDA receptor modulators on a blood–brain barrier in vitro modelBrain Research, 2011
- Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's DiseaseCell, 2010
- The diagnosis of young-onset dementiaThe Lancet Neurology, 2010
- Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's diseaseAlzheimer's Research & Therapy, 2010
- Structure and function of the blood–brain barrierNeurobiology of Disease, 2010
- Fluvastatin prevents glutamate-induced blood-brain-barrier disruption in vitroLife Sciences, 2008
- Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?Nature Reviews Molecular Cell Biology, 2007
- NMDA Receptor-Nitric Oxide Transmission Mediates Neuronal Iron Homeostasis via the GTPase Dexras1Neuron, 2006
- Blood transferrin and ferritin in Alzheimer's diseaseLife Sciences, 1997
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984